Total Funding
25
48
Total FundingSeries B raised
Growth Score
-4 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
249582
Hotgen is a diagnostic technology platform that develops liquid biopsy early screening technology.
Yong Zhan Shi: CFO, Secretary, Director & Deputy General Manager
About the Company
Hotgen engages in research, develops, and manufactures medical and public safety inspection products. It is a diagnostic technology platform that develops and expands liquid biopsy early screening technology for cancer and establishes a multi-omics diagnostic technology platform including protein markers, sugar chain exosomes, and DNA methylation.
Their technology deploys antibody drugs, live bacteria drugs, exosome drugs, and other biopharmaceutical fields and creates a development strategy for the entire industry chain, from diagnosis to treatment.
